GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report)’s share price passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $27.18 and traded as low as $23.80. GENMAB A/S/S shares last traded at $23.83, with a volume of 507,844 shares.
GENMAB A/S/S Stock Up 0.9 %
The stock has a fifty day moving average of $27.12 and a two-hundred day moving average of $27.89.
About GENMAB A/S/S
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).
See Also
- Five stocks we like better than GENMAB A/S/S
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- 3 Stocks to Consider Buying in October
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- The How and Why of Investing in Gold Stocks
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.
